一个KRAB/KAP1-miRNA级联通过特定阶段的线粒细胞衰变的控制来调节红色素形成
Isabelle Barde1, Benjamin Rauwel, Ray Marcel Marin-Florez
1School of Life Sciences and Frontiers in Genetics Program, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
概括
通过调节微RNAs,KRAB-ZFPs和KAP1控制血液细胞的发育. 这可以通过在红细胞形成过程中确保适当的线粒体和线粒体清除来预防贫血.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 血液形成依赖于转录因子和染色质修饰剂来进行血细胞分化.
- 含有KRAB的指蛋白 (KRAB-ZFPs) 和它们的辅因子KAP1与基因调节有关.
- 在红色形成中KRAB-ZFPs和KAP1的确切作用需要进一步阐明.
研究的目的:
- 研究KRAB-ZFPs和KAP1在造血分化的功能.
- 确定KRAB-ZFPs和KAP1调节红红细胞发育的分子机制.
- 探索KRAB/KAP1-miRNA途径在红色素形成过程中的菌作用.
主要方法:
- 在小鼠中,血液形成特异性的Kap1删除.
- 分析红细胞分化和线粒细胞缩标志物.
- 对食基因向的microRNA表达的量化.
主要成果:
- 在小鼠中,Kap1的缺失导致严重的低增殖性贫血.
- 缺乏Kap1的红质细胞表现出受损的线粒体和保留的线粒体.
- 在Kap1-被删除的红细胞细胞中观察到针对线粒细胞转录的特定微RNA的持续表达.
- 这种miRNA失调是由于阶段特定的KRAB-ZFPs的抑制失败造成的.
结论:
- 一个保存的KRAB/KAP1-miRNA调节级联控制了小鼠和人类的红色素形成过程中的菌.
- 这条途径代表了一个多层的转录性调节系统.
- 基于蛋白质和RNA的抑制剂以组合作用来控制关键的分化事件,例如线粒的启动.
相关概念视频
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Regulation of Expression at Multiple Steps
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...


